BeOne Medicines has secured approval from the European Commission (EC) for Tevimbra (tislelizumab) to be used along with ...

It is probable but unproven that Epstein–Barr virus (EBV) has a role in nasopharyngeal carcinoma. We determined whether antibodies against EBV are present before the development of ...

WebMD explains the causes, symptoms, and treatment of nasopharyngeal cancer -- a type of head and neck cancer.

The aim of this study was to determine the expression of Y-Box-binding protein-1 in nasopharyngeal cancer in vitro and in tumor tissue samples as well as analyze the clinicopathological ...

Screening for Epstein-Barr virus DNA in plasma samples identified nasopharyngeal carcinoma significantly earlier compared with historical controls.

Nasopharyngeal carcinoma (NPC), a malignancy that develops in the upper section of the throat behind the nose, occurs in ...

More information: Eugenia Li Ling Yeo et al, Tumor immune microenvironment delineates progression trajectories of distinct nasopharyngeal carcinoma phenotypes, Cell Reports Medicine (2025).

A retrospective review was therefore initiated to evaluate the frequency of elevated levels of serum tumor markers among pts with NPC. Methods: Using unique data mining software, all patients who were ...

Nasopharyngeal cancer starts in the area behind the nose, where it meets the throat (the nasopharynx). Find out about symptoms, causes, tests, treatment and about coping with it.

Adjuvant camrelizumab significantly improves event-free survival in patients with locoregionally advanced nasopharyngeal carcinoma, new data suggest.

By Shimona Patel: Nasopharyngeal cancer refers to a relatively uncommon malignancy that begins in the nasopharynx—the upper section of the throat located behind the nose and above the back of ...